Regeneron Pharmaceuticals
REGN
#231
Rank
NZ$136.65 B
Marketcap
$1,244
Share price
-0.90%
Change (1 day)
-7.02%
Change (1 year)

EPS for Regeneron Pharmaceuticals (REGN)

EPS in 2023 (TTM): $60.54

According to Regeneron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $66.19. In 2022 the company made an earnings per share (EPS) of $71.79 a decrease over its 2021 EPS that were of $135.45.

EPS history for Regeneron Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$60.54-15.67%
2022$71.79-47%
2021$135.45133.36%
2020$58.0469.13%
2019$34.32-14.44%
2018$40.11100.71%
2017$19.9931.78%
2016$15.1738.96%
2015$10.9172.55%
2014$6.33-17.55%
2013$7.67-44.98%
2012$13.94-422.54%
2011-$4.3292.13%
2010-$2.2549.41%
2009-$1.51-15.84%
2008-$1.79-36.88%
2007-$2.83-9.6%
2006-$3.144.12%
2005-$3.01-323.68%
2004$1.35-135.51%
2003-$3.79-24.38%
2002-$5.0156.35%
2001-$3.21187.3%
2000-$1.12-16%
1999-$1.33177.78%
1998-$0.48-35.71%
1997-$0.74-68.42%
1996-$2.36

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$25.07-62.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-$7.28-111.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$32.71-50.59%๐Ÿ‡บ๐Ÿ‡ธ USA
$24.96-62.30%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.63-89.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$5.63-91.49%๐Ÿ‡ซ๐Ÿ‡ท France